Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Maine Rx Rebate Program Stayed As PhRMA Mulls Supreme Court Case

Executive Summary

The Maine Rx Program will be prevented from going into effect until the end of July as the Pharmaceutical Research & Manufacturers of America considers whether it should pursue its case against the program to the U.S. Supreme Court.

You may also be interested in...



PhRMA v. Maine

Supreme Court requests brief from U.S. Solicitor General Theodore Olson before deciding whether to hear the Pharmaceutical Research & Manufacturers of America's case against the Maine drug discount program. Sen. Olympia Snowe (R-Maine) asks Olson in an Oct. 10 letter to request that the court not review the case, which would allow Maine to proceed with implementation of the program (1"The Pink Sheet" July 9, p. 3)

PhRMA v. Maine

Supreme Court requests brief from U.S. Solicitor General Theodore Olson before deciding whether to hear the Pharmaceutical Research & Manufacturers of America's case against the Maine drug discount program. Sen. Olympia Snowe (R-Maine) asks Olson in an Oct. 10 letter to request that the court not review the case, which would allow Maine to proceed with implementation of the program (1"The Pink Sheet" July 9, p. 3)

Florida Medicaid Formulary Challenged By PhRMA Lawsuit

Florida will continue implementation of state Medicaid supplemental rebate law pending a hearing on PhRMA's preliminary injunction request seeking to block the program.

Related Content

UsernamePublicRestriction

Register

PS038148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel